drugset / Trial / NCT00940901

Sildenafil for Treatment of Priapism in Men With Sickle Cell Anemia

NCT00940901

RandomizedParallel-groupTriple-blindTreatment

Summary

This research is being done to evaluate if the phosphodiesterase type 5 (PDE5) inhibitor sildenafil has an effect on the frequency of recurrent priapism and the quality of life of males with sickle cell disease (SCD).

Timeline

Start
2008-06
Primary completion
2012-11
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Sildenafil Unknown 50 mg Oral